Background
Skin cutaneous melanoma (SKCM) ranks among the most prevalent malignant tumors, highlighting the significance of identifying new research targets. In this study, our objective was to pinpoint pivotal genes implicated in SKCM pathogenesis and ascertain their potential as prognostic biomarkers.
Methods
Leveraging data from 1809 normal skin samples and 471 SKCM samples, we identified differentially expressed genes (DEGs). Using a comprehensive suite of bioinformatic analyses, including weighted gene co-expression network analysis (WGCNA), we elucidated the functions of these DEGs and singled out hub genes. Cox analyses and overall survival analyses underscored that elevated expression of these genes correlated with more favorable prognoses.
Results
Ultimately, we identified five genes (
PLAC8, IL4I1, ZNF80, CCR8, CLEC4C
) as novel prognostic markers for SKCM. Furthermore, multivariate Cox analyses pinpointed
ZNF80
and
CCR8
as independent prognostic biomarkers. Experimental validation targeting these genes revealed significant downregulation in melanoma cells, except for
CCR8
. Subsequent knockdown of
IL4I1
promoted both the proliferation and inhibited the apoptosis of melanoma cells.
Conclusion
In summary, our study identified a series of potential prognostic genes in melanoma and verified the functional role of
IL4I1
among them.